ALVAREZ CESAR L 4
Research Summary
AI-generated summary
PRECIGEN (PGEN) Director Cesar L. Alvarez Receives Award
What Happened
Cesar L. Alvarez, a director of Precigen, Inc. (PGEN), was granted equity awards on March 10, 2026. He received 17,806 common shares issued in lieu of an annual retainer valued at $3.51 per share (total $62,499). In addition, he was granted 35,612 and 41,073 restricted stock units (RSUs) — a combined 76,685 RSUs — recorded as derivatives with $0 immediate cash value.
Key Details
- Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (no late filing indicated).
- Grants: 17,806 shares @ $3.51 = $62,499; 35,612 RSUs @ $0; 41,073 RSUs @ $0.
- RSU total: 76,685 RSUs (derivative awards that represent contingent rights to receive shares).
- Vesting/other footnotes: Shares issued in lieu of a $62,500 annual retainer (F1). Each RSU equals one share (F2). RSUs vest in full on March 10, 2027 (F3).
- Shares owned after transaction: not specified in the filing.
Context
These awards are compensation (director retainer and RSUs) rather than open-market purchases or sales. The 17,806 shares were issued immediately as payment in lieu of cash; the RSUs are contingent and only convert to actual shares if/when they vest on March 10, 2027. Such grants are routine for board compensation and do not by themselves signal an insider buying or selling stock for investment reasons.